Medical economics

US drugmaker Eli Lilly says slashing insulin prices by 70%

US pharmaceutical giant Eli Lilly announced Wednesday it was cutting the cost of its most commonly prescribed insulins by 70 percent after years of soaring prices that hit millions of Americans living with diabetes.

page 2 from 4